Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management.
Junkins-Hopkins
Jacqueline M
JM
Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. jjunkin1@jhmi.edu
D000752:Anemia, Pernicious / Q000175:diagnosis / Q000453:epidemiology; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000453:epidemiology; D015897:Comorbidity; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D003874:Dermatitis Herpetiformis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D003879:Dermatologic Agents / Q000627:therapeutic use; D003880:Dermatology / Q000193:education / Q000379:methods; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000453:epidemiology; D004502:Education, Medical, Continuing; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000453:epidemiology; D008223:Lymphoma / Q000175:diagnosis / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000453:epidemiology; D012955:Societies, Medical; D016896:Treatment Outcome; D014741:Video Recording
D003879:Dermatologic Agents; D003622:Dapsone